Clinical Trial Update: Immunization To Prevent Acute COPD Exacerbations

View source ↗

Summary

Pfizer conducted an immunization trial aimed at preventing acute exacerbations of chronic obstructive pulmonary disease, which has been terminated. Results from…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Pneumococcal Infections

Drugs mentioned

• Pfizer Pneumococcal Vaccine (unspecified)

Snippet

Sponsor: Pfizer | Conditions: Pneumococcal Infections, COPD | Status: TERMINATED | Results posted: 2024-08-19